Abbott’s Amulet 360 achieves complete LAA closure in 96.3% of evaluated patients at one year
ABT•Abbott announced one-year VERITAS results showing complete left atrial appendage closure with its Amulet 360 device in 96.3% of evaluated patients, with low stroke incidence. The results were presented Nov. 1, 2026, and published in JACC: Cardiovascular Interventions.
1. One-year VERITAS results
Abbott announced that its Amulet 360 device achieved complete left atrial appendage closure in 96.3% of evaluated patients at one year, with low stroke incidence. The results were presented Nov. 1, 2026, at the Transcatheter Cardiovascular Therapeutics conference and published in JACC: Cardiovascular Interventions; Amulet 360 remains investigational in the U.S. and received CE Mark approval in August 2026.
